• Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

  • Nov 1 2023
  • Duración: 1 h y 24 m
  • Podcast

Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • "I don't know how I'm going to live with myself if I don't stay true to what I believe." We evaluate the recent published work describing apabetalone, a small molecule drug from Resverlogix Corp that has been around for awhile and in clinic for other indications and is now being assessed more seriously as a potential therapeutic for FSHD. Overall, while lacking in some areas, this initial study is generally positive and supports that it is a new candidate worthy of further evaluation.
    Más Menos
Gestión Economía
Más Menos

Lo que los oyentes dicen sobre Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles